Literature DB >> 3859366

Expression of neoplasia-related proteins of chemically transformed HuT fibroblasts in human osteosarcoma HOS fibroblasts and modulation of actin expression upon elevation of tumorigenic potential.

D Goldstein, J Leavitt.   

Abstract

Two sets of abundant cytoplasmic transformation-specific polypeptides, p788/p789 and p219/p220, have been identified by comparing in vitro-transformed human fibroblasts with diploid human fibroblasts. These polypeptides are also expressed by the human fibrosarcoma and osteosarcoma cell lines HT1080 the human fibrosarcoma and osteosarcoma cell lines HT1080 and HOS, respectively. HOS cells, however, synthesize only one of the two electrophoretic forms of each marker set, p789 and p219, at greatly reduced rates compared to the rates of synthesis found for HT1080 cells and the in vitro-transformed cell lines. Induction of expression of these neoplastic marker polypeptides is independent of the activation of a transforming gene that will induce focus formation in confluent mouse 3T3 cell monolayers. Activation of the met oncogene in MNNG-HOS cells and simultaneous elevation of tumorigenic potential did not lead to a significant change in the rate of the 600 most abundant polypeptide species with the exception of one of the two cytoplasmic actin polypeptides. While the normal ratio of beta-to gamma-actin which is approximately 2:1 was expressed in "untransformed" HOS cells, MNNG-HOS cells synthesized 50% less beta-actin resulting in a 1:1 ratio of beta-actin to gamma-actin. Our finding here, together with our previous characterization of the human beta-actin gene, leads us to predict that one of two functional beta-actin genes expressed in HOS cells has been inactivated in MNNG-HOS cells by either a regulatory or structural gene mutation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3859366

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy.

Authors:  Putri A Agustian; Mario Schiffer; Wilfried Gwinner; Irini Schäfer; Katharina Theophile; Friedrich Modde; Clemens L Bockmeyer; Jana Traeder; Ulrich Lehmann; Anika Grosshennig; Hans H Kreipe; Verena Bröcker; Jan U Becker
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Expression of fatty acyl-CoA binding proteins in colon cells: response to butyrate and transformation.

Authors:  R E Gossett; F Schroeder; J M Gunn; A B Kier
Journal:  Lipids       Date:  1997-06       Impact factor: 1.880

Review 3.  Molecular genetics of actin function.

Authors:  E S Hennessey; D R Drummond; J C Sparrow
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

4.  Expression of transfected mutant beta-actin genes: alterations of cell morphology and evidence for autoregulation in actin pools.

Authors:  J Leavitt; S Y Ng; U Aebi; M Varma; G Latter; S Burbeck; L Kedes; P Gunning
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

5.  Expression of transfected mutant beta-actin genes: transitions toward the stable tumorigenic state.

Authors:  J Leavitt; S Y Ng; M Varma; G Latter; S Burbeck; P Gunning; L Kedes
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

6.  Tropomyosin isoform switching in tumorigenic human fibroblasts.

Authors:  J Leavitt; G Latter; L Lutomski; D Goldstein; S Burbeck
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

7.  Molecular cloning and characterization of plastin, a human leukocyte protein expressed in transformed human fibroblasts.

Authors:  C S Lin; R H Aebersold; S B Kent; M Varma; J Leavitt
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

8.  Modulation of microfilament protein composition by transfected cytoskeletal actin genes.

Authors:  S Y Ng; H Erba; G Latter; L Kedes; J Leavitt
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

9.  Altered expression of a third actin accompanying malignant progression in mouse B16 melanoma cells.

Authors:  S Taniguchi; H Sadano; T Kakunaga; T Baba
Journal:  Jpn J Cancer Res       Date:  1989-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.